The word Bifantis is simply the trademarked name for a strain of probiotic bacteria - Bifidobacterium infantis 35624 - found in the supplement Align.
B infantis is an anaerobic species that does not require oxygen and produces lactic and acetic acids, both of which prevent the colonization of harmful pathogens.
It also assists the immune system and moderates many gastrointesinal problems such as IBS, constipation, diarrhea, abdominal discomfort, gas and bloating.
Currently Align is the only source of this particluar strain of Bifidobacterium.
The supplement Align is one of most researched probiotics about with over a dozen studies. These all point to it helping with IBS and to the reduction of pain caused through intestinal bloating2.
The "ideal" dose has been shown to be 1 hundred million cfu so the number of cfu in this Bifantis supplement is set at slightly more to give a built in safety margin incase there is lack of optimum storage. You can read my review of Align Probiotic or my personal experience with Align and antibiotic diarrhea. It certainnly stopped me from getting AAD and in similar circumstances I would take it again.
You can buy Bifantis in Align Daily Probiotic Supplement Capsules.
A 2009 study published in the Rev Gastroenterol Disord. 2009 Winter;9(1):7-15. stated:"Although their exact mechanisms of action remain elusive, it is clear that the beneficial properties inherent to each probiotic species are strain specific. Bifidobacterium infantis 35624 ( B infantis 35624 is a probiotic with unique abilities to reduce intestinal inflammation. Two randomized, controlled trials have validated its efficacy for treating both individual and global IBS symptoms without evidence to suggest an increase in adverse events. B. infantis 35624 appears safe and effective for the treatment of IBS."
1. Peter J. Whorwell. Do Probiotics Improve Symptoms in Patients with Irritable Bowel Syndrome? Therap Adv Gastroenterol. 2009 July; 2(4_supplement): 37–44.
2. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil. 2010 Sep;22(9):1029-35, e268. Epub 2010 Jun 1.